MedTrace Logo

Adenosine Testing to DEtermine the Need for Pacing Therapy

NCT01481168 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-11-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not the intravenous adenosine test readily identifies patients with unexplained syncope who would benefit from permanent pacemaker implantation.

Conditions

  • Syncope

Interventions

DEVICE

Pacemaker implantation (Medtronic)

DDD+/-R pacing

DEVICE

Pacemaker implantation (Medtronic)

ODO pacing

DEVICE

Implantable Loop Recorder (Medtronic)

Loop recorder implantation

Sponsors & Collaborators

  • Newcastle-upon-Tyne Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Steve W Parry, PhD, MBBS, MRCP, BSc · Institue of Ageing and Health, University of Newcastle

  • Chris J Pummer, PhD, MRCP, BMBCh, BSc · Newcastle upon Tyne Hospitals NHS FOundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-12
Primary Completion
2017-01-26
Completion
2017-01-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01481168 on ClinicalTrials.gov